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2352-3042Abstract The majority of clinical blindness is caused by a loss of transparency of the lens and
cornea, largely due to cataracts and corneal injuries. The most common treatment used to
restore the transparency is surgical removal of the damaged tissues, followed by transplanta-
tion of donated corneal tissue or an artificial lens. However, these therapies are not without
limitations or untoward effects. Unraveling the intricate regulatory signals required for cornea
and lens development has made it possible to harness the lineage growth potential of stem
cells for cornea repair and lens regeneration, as showcased in two recent studies published
in the March 17th issue of Nature.Cataracts and corneal injuries are the leading causes of
clinical blindness worldwide due to the resulting loss of the
transparency of the lens and cornea. The most common
treatment intended to restore the transparency is surgical
removal of the damaged tissues, which is followed by
transplantation of donated corneal tissue or an artificial
lens. However, these therapies are not without limitations
and untoward effects. There has been a continuous hunt for
alternative cell/tissue sources to transform the treatment.
A major driving force behind the recent advances in the
treatment of blindness is the explosive progress made in
the field of stem cell biology, particularly with regard to
somatic pluripotency, self-renewal, and directed tissue-
specific differentiation. The unraveling of the intricate
regulatory signals of corneal and lens stem cells has made it
possible to harness the lineage growth potential of stem
cells to provide better cornea repair and lens regeneration.
This was showcased in two recent studies published in the
March 17th issue of Nature.
In one report by Hayashi, et al, cornea epithelial con-
structs grown and differentiated from human induced
pluripotent stem cells (iPSCs) were put to the test in aity of Chongqing Medical
16.03.003rabbit model of corneal injury.1 A rapid repair of the
corneal epithelium was observed within the first two
weeks post-transplantation compared to the surgical
control. Although the long-term engraftment and well-
being of the repaired cornea has not been tested in this
rabbit model, these early findings demonstrated the po-
tential of iPS cells as an alternative source for clinical
cornea repair. Their use may supplant that of somatic
limbal epithelial stem cells (LESC), which have been
extensively studied as a preferred source for therapeutic
ends.2 Whether these iPSC-based corneal derivatives are
functionally superior to those grown from LESC remains
unclear. In contrast to LESC, two major challenges remain
before the clinical benefit of iPS cells can be realized. One
of these challenges is the lengthy time, and thus the
prohibitive cost, required to develop patient-specific
iPSCs and their derivative corneal constructs. Another
challenge is to ascertain the long-term safety of iPSC-
derived cells since induced pluripotency requires the
ectopic activation of multiple pluripotency genes, which
are also associated with cancerous growth.
To avoid these obstacles, the SEAM culture model used by
Hayashi, et al to differentiate iPSCs into various lineages of
eye tissues may serve as a petri dish platform to dissect the
molecular signals required during embryonic eye
104 View on newsdevelopment. The knowledge gained will have a funda-
mental impact on the manipulation of the eye stem cell
environment, making it possible to achieve de novo regen-
eration with minimal molecular and cellular intervention.
The proof of this “organic” approach has just arrived in a
second study appeared in the same issue of Nature by Lin,
et al who searched for ways to regenerate damaged lens
tissues.3 In this study, Lin and colleagues were able to
identify the anatomical location of lens epithelial stem/
progenitor cells (LEC) in both animal and human tissues.
These cells are known to have a role in lens homeostasis and
regeneration. Through injury modeling, they confirmed the
proliferative response of the endogenous LEC cells based on
the expression of several marker genes. Using the knowledge
gained in these studies, a less invasive surgery protocol was
devised to remove the cataract tissue. This new protocol
employed a small peripheral incision on the lens capsule that
maximally preserved the residing LEC pool in the capsule.
Using this method, the authors were able to coax the
regeneration of a functional lens in the experimental ani-
mals. Their success was duplicated in their ensuing clinical
trial where they treated infants with congenital cataracts.
Although these paradigm-shifting findings seemed to
work well in infant patients, it may be difficult to repro-
duce them during the treatment of adult cataracts due to
the different characteristics of age-related cataracts and
the diminished LEC pool present in older patients. Further
studies are therefore needed, but these preliminary studies
provide a ray of hope for better treatments.
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